Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 354

1.

Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.

Mishra N, Ng TFF, Marine RL, Jain K, Ng J, Thakkar R, Caciula A, Price A, Garcia JA, Burns JC, Thakur KT, Hetzler KL, Routh JA, Konopka-Anstadt JL, Nix WA, Tokarz R, Briese T, Oberste MS, Lipkin WI.

MBio. 2019 Aug 13;10(4). pii: e01903-19. doi: 10.1128/mBio.01903-19.

2.

Cyclosporine and coronary outcomes in Kawasaki disease.

Burns JC.

J Pediatr. 2019 Jul;210:239-242. doi: 10.1016/j.jpeds.2019.04.044. No abstract available.

PMID:
31234982
3.

Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population.

Son MBF, Gauvreau K, Tremoulet AH, Lo M, Baker AL, de Ferranti S, Dedeoglu F, Sundel RP, Friedman KG, Burns JC, Newburger JW.

J Am Heart Assoc. 2019 Jun 4;8(11):e011319. doi: 10.1161/JAHA.118.011319.

4.

HLA-C variants associated with amino acid substitutions in the peptide binding groove influence susceptibility to Kawasaki disease.

Shimizu C, Kim J, Eleftherohorinou H, Wright VJ, Hoang LT, Tremoulet AH, Franco A, Hibberd ML, Takahashi A, Kubo M, Ito K, Tanaka T, Onouchi Y, Coin LJM, Levin M, Burns JC, Shike H; International Kawasaki Disease Genetic Consortium.

Hum Immunol. 2019 May 20. pii: S0198-8859(18)31016-4. doi: 10.1016/j.humimm.2019.04.020. [Epub ahead of print]

PMID:
31122742
5.

Author Correction: Clustering and climate associations of Kawasaki Disease in San Diego County suggest environmental triggers.

Rypdal M, Rypdal V, Burney JA, Cayan D, Bainto E, Skochko S, Tremoulet AH, Creamean J, Shimizu C, Kim J, Burns JC.

Sci Rep. 2019 May 9;9(1):7401. doi: 10.1038/s41598-019-42137-6.

6.

Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.

Dionne A, Burns JC, Dahdah N, Tremoulet AH, Gauvreau K, de Ferranti SD, Baker AL, Son MB, Gould P, Fournier A, Newburger JW, Friedman KG.

Pediatrics. 2019 Jun;143(6). pii: e20183341. doi: 10.1542/peds.2018-3341. Epub 2019 May 2.

PMID:
31048414
7.

Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease.

Nagelkerke SQ, Tacke CE, Breunis WB, Tanck MWT, Geissler J, Png E, Hoang LT, van der Heijden J, Naim ANM, Yeung RSM, Levin ML, Wright VJ, Burgner DP, Ponsonby AL, Ellis JA, Cimaz R, Shimizu C, Burns JC, Fijnvandraat K, van der Schoot CE, van den Berg TK, de Boer M, Davila S, Hibberd ML, Kuijpers TW; International Kawasaki Disease Genetics Consortium.

Front Immunol. 2019 Mar 21;10:185. doi: 10.3389/fimmu.2019.00185. eCollection 2019.

8.

Circulating Markers of Inflammation Persist in Children and Adults With Giant Aneurysms After Kawasaki Disease.

Lech M, Guess J, Duffner J, Oyamada J, Shimizu C, Hoshino S, Farutin V, Bulik DA, Gutierrez B, Sarvaiya H, Kapoor B, Koppes L, Saldova R, Stockmann H, Albrecht S, McManus C, Rudd PM, Kaundinya GV, Manning AM, Bosques CJ, Kahn AM, Daniels LB, Gordon JB, Tremoulet AH, Capila I, Gunay NS, Ling LE, Burns JC.

Circ Genom Precis Med. 2019 Apr;12(4):e002433. doi: 10.1161/CIRCGEN.118.002433. Epub 2019 Mar 7.

PMID:
30844302
9.

The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.

Roberts SC, Jain S, Tremoulet AH, Kim KK, Burns JC; KIDCARE Multicenter Study Group, Anand V, Anderson M, Ang J, Ansusinha E, Arditi M, Ashouri N, Bartlett A, Chatterjee A, DeBiasi R, Dekker C, DeZure C, Didion L, Dominguez S, El Feghaly R, Erdem G, Halasa N, Harahsheh A, Jackson MA, Jaggi P, Jain S, Jone PN, Kaushik N, Kurio G, Lillian A, Lloyd D, Manaloor J, McNelis A, Michalik DE, Newburger J, Newcomer C, Perkins T, Portman M, Romero J, Ronis T, Rowley A, Schneider K, Schuster J, Tejtel SKS, Sharma K, Simonsen K, Szmuszkovicz J, Truong D, Wood J, Yeh S.

Contemp Clin Trials. 2019 Apr;79:98-103. doi: 10.1016/j.cct.2019.02.008. Epub 2019 Mar 3.

PMID:
30840903
10.

Hemodynamic variables in aneurysms are associated with thrombotic risk in children with Kawasaki disease.

Grande Gutierrez N, Mathew M, McCrindle BW, Tran JS, Kahn AM, Burns JC, Marsden AL.

Int J Cardiol. 2019 Apr 15;281:15-21. doi: 10.1016/j.ijcard.2019.01.092. Epub 2019 Jan 28.

PMID:
30728104
11.

New perspectives on Kawasaki disease.

Burns JC.

Arch Dis Child. 2019 Jul;104(7):616-617. doi: 10.1136/archdischild-2018-316322. Epub 2019 Jan 30. No abstract available.

PMID:
30700406
12.

How Should We Classify Kawasaki Disease?

Marrani E, Burns JC, Cimaz R.

Front Immunol. 2018 Dec 14;9:2974. doi: 10.3389/fimmu.2018.02974. eCollection 2018. Review.

13.

Characterization of spatial and temporal development of Type I and Type II hair cells in the mouse utricle using new cell-type-specific markers.

McInturff S, Burns JC, Kelley MW.

Biol Open. 2018 Nov 19;7(11). pii: bio038083. doi: 10.1242/bio.038083.

14.

Clustering and climate associations of Kawasaki Disease in San Diego County suggest environmental triggers.

Rypdal M, Rypdal V, Burney JA, Cayan D, Bainto E, Skochko S, Tremoulet AH, Creamean J, Shimizu C, Kim J, Burns JC.

Sci Rep. 2018 Nov 12;8(1):16140. doi: 10.1038/s41598-018-33124-4. Erratum in: Sci Rep. 2019 May 9;9(1):7401.

15.

Bifid T waves on the ECG and genetic variation in calcium channel voltage-dependent beta 2 subunit gene (CACNB2) in acute Kawasaki disease.

Oyamada J, Shimizu C, Kim J, Williams MR, Png E, Hibberd ML, Tremoulet AH, Perry JC, Burns JC.

Congenit Heart Dis. 2019 Mar;14(2):213-220. doi: 10.1111/chd.12696. Epub 2018 Nov 5.

PMID:
30395415
16.

Kawasaki disease: an essential comparison of coronary artery aneurysm criteria.

Burns JC, Hoshino S, Kobayashi T.

Lancet Child Adolesc Health. 2018 Dec;2(12):840-841. doi: 10.1016/S2352-4642(18)30334-1. Epub 2018 Oct 16. No abstract available.

PMID:
30337184
17.

Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease.

de Ferranti SD, Gauvreau K, Friedman KG, Tang A, Baker AL, Fulton DR, Tremoulet AH, Burns JC, Newburger JW.

JAMA Pediatr. 2018 Dec 1;172(12):e183310. doi: 10.1001/jamapediatrics.2018.3310. Epub 2018 Dec 3.

18.

Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience.

Skochko SM, Jain S, Sun X, Sivilay N, Kanegaye JT, Pancheri J, Shimizu C, Sheets R, Tremoulet AH, Burns JC.

J Pediatr. 2018 Dec;203:408-415.e3. doi: 10.1016/j.jpeds.2018.07.090. Epub 2018 Sep 26.

PMID:
30268398
19.

Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature.

Wright VJ, Herberg JA, Kaforou M, Shimizu C, Eleftherohorinou H, Shailes H, Barendregt AM, Menikou S, Gormley S, Berk M, Hoang LT, Tremoulet AH, Kanegaye JT, Coin LJM, Glodé MP, Hibberd M, Kuijpers TW, Hoggart CJ, Burns JC, Levin M; Immunopathology of Respiratory, Inflammatory and Infectious Disease Study (IRIS) Consortium and the Pediatric Emergency Medicine Kawasaki Disease Research Group (PEMKDRG).

JAMA Pediatr. 2018 Oct 1;172(10):e182293. doi: 10.1001/jamapediatrics.2018.2293. Epub 2018 Oct 1.

20.

Hair Cell Mechanotransduction Regulates Spontaneous Activity and Spiral Ganglion Subtype Specification in the Auditory System.

Sun S, Babola T, Pregernig G, So KS, Nguyen M, Su SM, Palermo AT, Bergles DE, Burns JC, Müller U.

Cell. 2018 Aug 23;174(5):1247-1263.e15. doi: 10.1016/j.cell.2018.07.008. Epub 2018 Aug 2.

21.

New insights into cardiovascular disease in patients with Kawasaki disease.

Burns JC, Matsubara T.

Curr Opin Pediatr. 2018 Oct;30(5):623-627. doi: 10.1097/MOP.0000000000000673. Review.

22.

Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease.

Jaggi P, Mejias A, Xu Z, Yin H, Moore-Clingenpeel M, Smith B, Burns JC, Tremoulet AH, Jordan-Villegas A, Chaussabel D, Texter K, Pascual V, Ramilo O.

PLoS One. 2018 May 29;13(5):e0197858. doi: 10.1371/journal.pone.0197858. eCollection 2018.

23.

Letter to the Editor on Chronic fibrosing osteomyelitis of the jaws: an important cause of recalcitrant facial pain. A clinicopathologic study of 331 cases in 227 patients by Goldblatt LI, Adams WR, Spolnik KJ, Deardorf KA, Parks ET.

Klasser GD, Laskin DM, Greene CS, Burns JC.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Apr 17. pii: S2212-4403(18)30881-2. doi: 10.1016/j.oooo.2018.02.743. [Epub ahead of print] No abstract available.

PMID:
29748037
24.

Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki Disease.

Vande Casteele N, Oyamada J, Shimizu C, Best BM, Capparelli EV, Tremoulet AH, Burns JC.

Clin Pharmacokinet. 2018 Dec;57(12):1593-1601. doi: 10.1007/s40262-018-0653-6.

PMID:
29623653
25.

Management of sequelae of Kawasaki disease in adults.

Gordon JB, Burns JC.

Glob Cardiol Sci Pract. 2017 Oct 31;2017(3):e201731. doi: 10.21542/gcsp.2017.31. Review.

26.

Frequently asked questions regarding treatment of Kawasaki disease.

Burns JC.

Glob Cardiol Sci Pract. 2017 Oct 31;2017(3):e201730. doi: 10.21542/gcsp.2017.30. Review. No abstract available.

27.

Computational blood flow simulations in Kawasaki disease patients: Insight into coronary artery aneurysm hemodynamics.

Grande Gutierrez N, Kahn A, Burns JC, Marsden AL.

Glob Cardiol Sci Pract. 2017 Oct 31;2017(3):e201729. doi: 10.21542/gcsp.2017.29. No abstract available.

28.

Finding Kawasaki Disease.

Burns JC.

Can J Cardiol. 2018 Mar;34(3):236-237. doi: 10.1016/j.cjca.2017.12.027. Epub 2017 Dec 30. No abstract available.

29.

Putting Out the Fire in Acute Kawasaki Disease.

Burns JC, Vande Casteele N.

J Pediatr. 2018 Apr;195:11-13.e1. doi: 10.1016/j.jpeds.2017.12.039. Epub 2018 Feb 1. No abstract available.

PMID:
29395176
30.

Pediatric tolerogenic DCs expressing CD4 and immunoglobulin-like transcript receptor (ILT)-4 secrete IL-10 in response to Fc and adenosine.

Franco A, Kumar J, Lin G, Behnamfar N, Hsieh LE, Shimizu C, Tremoulet AH, Burns JC, Linden J.

Eur J Immunol. 2018 Mar;48(3):482-491. doi: 10.1002/eji.201747139. Epub 2018 Jan 15.

31.

Computed Tomography Coronary Angiography for Evaluation of Children With Kawasaki Disease.

Singhal M, Singh S, Gupta P, Sharma A, Khandelwal N, Burns JC.

Curr Probl Diagn Radiol. 2018 Jul - Aug;47(4):238-244. doi: 10.1067/j.cpradiol.2017.09.013. Epub 2017 Oct 23.

32.

History of the worldwide emergence of Kawasaki disease.

Burns JC.

Int J Rheum Dis. 2018 Jan;21(1):13-15. doi: 10.1111/1756-185X.13214. Epub 2017 Nov 19. Review.

33.

Molecular architecture underlying fluid absorption by the developing inner ear.

Honda K, Kim SH, Kelly MC, Burns JC, Constance L, Li X, Zhou F, Hoa M, Kelley MW, Wangemann P, Morell RJ, Griffith AJ.

Elife. 2017 Oct 10;6. pii: e26851. doi: 10.7554/eLife.26851.

34.

Urotensin 2 in Kawasaki disease pathogenesis.

Huang CY, Burns JC, Shimizu C.

Pediatr Res. 2017 Dec;82(6):1048-1055. doi: 10.1038/pr.2017.183. Epub 2017 Aug 16.

PMID:
28753597
35.

Assessment of Coronary Artery Aneurysms Caused by Kawasaki Disease Using Transluminal Attenuation Gradient Analysis of Computerized Tomography Angiograms.

Grande Gutierrez N, Shirinsky O, Gagarina N, Lyskina G, Fukazawa R, Ogawa S, Burns JC, Marsden AL, Kahn AM.

Am J Cardiol. 2017 Aug 15;120(4):556-562. doi: 10.1016/j.amjcard.2017.05.025. Epub 2017 May 30.

36.

High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease.

Salgado AP, Ashouri N, Berry EK, Sun X, Jain S, Burns JC, Tremoulet AH.

J Pediatr. 2017 Jun;185:112-116.e1. doi: 10.1016/j.jpeds.2017.03.025. Epub 2017 Apr 10.

37.

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention.

Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29. Review. Erratum in: Circulation. 2019 Jul 30;140(5):e181-e184.

PMID:
28356445
38.

Usefulness of Calcium Scoring as a Screening Examination in Patients With a History of Kawasaki Disease.

Kahn AM, Budoff MJ, Daniels LB, Oyamada J, Gordon JB, Burns JC.

Am J Cardiol. 2017 Apr 1;119(7):967-971. doi: 10.1016/j.amjcard.2016.11.055. Epub 2017 Jan 6.

39.

Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility.

Kim J, Shimizu C, Kingsmore SF, Veeraraghavan N, Levy E, Ribeiro Dos Santos AM, Yang H, Flatley J, Hoang LT, Hibberd ML, Tremoulet AH, Harismendy O, Ohno-Machado L, Burns JC.

PLoS One. 2017 Feb 2;12(2):e0170977. doi: 10.1371/journal.pone.0170977. eCollection 2017.

40.

PRINCESS: Privacy-protecting Rare disease International Network Collaboration via Encryption through Software guard extensionS.

Chen F, Wang S, Jiang X, Ding S, Lu Y, Kim J, Sahinalp SC, Shimizu C, Burns JC, Wright VJ, Png E, Hibberd ML, Lloyd DD, Yang H, Telenti A, Bloss CS, Fox D, Lauter K, Ohno-Machado L.

Bioinformatics. 2017 Mar 15;33(6):871-878. doi: 10.1093/bioinformatics/btw758.

41.

Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.

Wang Y, Li Z, Hu G, Hao S, Deng X, Huang M, Ren M, Jiang X, Kanegaye JT, Ha KS, Lee J, Li X, Jiang X, Yu Y, Tremoulet AH, Burns JC, Whitin JC, Shin AY, Sylvester KG, McElhinney DB, Cohen HJ, Ling XB; Pediatric Emergency Medicine Kawasaki Disease Research Group.

PLoS One. 2016 Dec 21;11(12):e0167434. doi: 10.1371/journal.pone.0167434. eCollection 2016.

42.

miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.

He M, Chen Z, Martin M, Zhang J, Sangwung P, Woo B, Tremoulet AH, Shimizu C, Jain MK, Burns JC, Shyy JY.

Circ Res. 2017 Jan 20;120(2):354-365. doi: 10.1161/CIRCRESAHA.116.310233. Epub 2016 Dec 6.

43.

Safety of Infliximab Following Live Virus Vaccination in Kawasaki Disease Patients.

Lee AM, Burns JC, Tremoulet AH.

Pediatr Infect Dis J. 2017 Apr;36(4):435-437. doi: 10.1097/INF.0000000000001447.

PMID:
27918378
44.

Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities.

Shimizu C, Eleftherohorinou H, Wright VJ, Kim J, Alphonse MP, Perry JC, Cimaz R, Burgner D, Dahdah N, Hoang LT, Khor CC, Salgado A, Tremoulet AH, Davila S, Kuijpers TW, Hibberd ML, Johnson TA, Takahashi A, Tsunoda T, Kubo M, Tanaka T, Onouchi Y, Yeung RS, Coin LJ, Levin M, Burns JC; International Kawasaki Disease Genetics Consortium.

Circ Cardiovasc Genet. 2016 Dec;9(6):559-568. doi: 10.1161/CIRCGENETICS.116.001533. Epub 2016 Nov 21.

45.

Development and regeneration of vestibular hair cells in mammals.

Burns JC, Stone JS.

Semin Cell Dev Biol. 2017 May;65:96-105. doi: 10.1016/j.semcdb.2016.11.001. Epub 2016 Nov 15. Review.

46.

Extreme giant aneurysms of three coronary arteries causing heart failure as late sequelae of Kawasaki disease.

Ammirati E, Burns JC, Moreo A, Daniels LB, Oliva F.

Eur Heart J. 2017 Mar 7;38(10):759-760. doi: 10.1093/eurheartj/ehw510. No abstract available.

PMID:
27816942
47.

Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.

Burns JC, Koné-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M.

Arthritis Rheumatol. 2017 Feb;69(2):268-276. doi: 10.1002/art.39975. Review. No abstract available.

48.

Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.

Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.

J Am Heart Assoc. 2016 Sep 15;5(9). pii: e003289. doi: 10.1161/JAHA.116.003289.

49.

Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.

Connelly MA, Shimizu C, Winegar DA, Shalaurova I, Pourfarzib R, Otvos JD, Kanegaye JT, Tremoulet AH, Burns JC.

BMC Pediatr. 2016 Sep 5;16(1):151. doi: 10.1186/s12887-016-0688-5.

50.

Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children.

Herberg JA, Kaforou M, Wright VJ, Shailes H, Eleftherohorinou H, Hoggart CJ, Cebey-López M, Carter MJ, Janes VA, Gormley S, Shimizu C, Tremoulet AH, Barendregt AM, Salas A, Kanegaye J, Pollard AJ, Faust SN, Patel S, Kuijpers T, Martinón-Torres F, Burns JC, Coin LJ, Levin M; IRIS Consortium.

JAMA. 2016 Aug 23-30;316(8):835-45. doi: 10.1001/jama.2016.11236. Erratum in: JAMA. 2017 Feb 7;317(5):538.

Supplemental Content

Loading ...
Support Center